Speech by Federal Chancellor Dr. Angela Merkel at the World Health Organization (WHO) Science Summit on November 15, 2021, as a video message:

Germany Angela Merkel · Former Chancellor of Germany

15 November 2021 · WHO Science Summit

Context
Merkel addressed the WHO Science Summit via video message on November 15, 2021, reflecting on COVID-19 lessons and global health cooperation.
Main themes
Pandemic preparedness, international health research cooperation, COVID-19 response, vaccine equity and Covax, science-policy interface, global health data and intelligence, WHO SAGO establishment, digitalization in healthcare, research funding, ACT-Accelerator, WHO Hub for Pandemic Intelligence in Berlin
Duration
~9 min
31st percentile
Words
1,074
31st percentile
Sentences
62
41st percentile
Readability
42
40th percentile
Grade
11.8
42nd percentile
Syntax
2.86
29th percentile
Vocabulary
2.28
69th percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Institutional 26%26%
  • Social 19%19%
  • Technological 16%16%
  • Ceremonial 16%16%
  • Economic 13%13%
  • Geopolitical 10%10%
  • Environmental 0%0%
  • Not in focus 0%

62 sentences in 20 paragraphs

Dear Director-General, dear Tedros,

dear Michelle Bachelet,

dear Ban Ki-moon,

dear Dr. Swaminathan,

esteemed ladies and gentlemen,

thank you very much, dear Tedros, for the invitation to speak here at the WHO Science Summit.

When an outbreak of disease develops from an epidemic into a pandemic, it is all the more reason to seek the counsel of science. What kind of pathogen are we dealing with? What needs to be done—locally, nationally, and globally—to contain the spread of infection? How can we share findings and ultimately effective assistance as quickly as possible?

At the end of 2019 and the beginning of 2020, we had very little knowledge about the pathogen SARS-CoV-2. Coronaviruses, however, were not entirely unknown. Research on this has been ongoing in Germany since 2006. But it has once again shown how important international networking in health research is. I am grateful to all the expert teams around the world for sharing their knowledge at an incredible speed to decode the SARS-CoV-2 virus. By mid-January 2020, there was a first PCR test for diagnostics. And in less than a year, effective and safe vaccines were developed. This was a milestone in managing the pandemic. As the German Chancellor, I am of course pleased that experts from Germany were also involved.

As important as it is for scientists to network well, they also need a good connection to politics. In any case, it is essential to ensure adequate national and international research funding. This is what research progress should and must be worth to us, especially when it comes to the health of all of us. These commitments must be reliable.

Unfortunately, not every country can maintain research capacities to the extent that would be desirable. Against this backdrop, the importance of the global initiative ACT-Accelerator and its vaccine pillar Covax becomes evident. With this, we have financially supported research on vaccines, therapeutics, and diagnostics, and we have also provided vaccines to poorer countries. In addition, the G20 countries have committed to significantly improving global access to the urgently needed vaccines, therapeutics, and diagnostics. This brings us closer to the WHO-recommended goal of vaccinating at least 40 percent of the population in all countries by the end of 2021 and at least 70 percent by mid-2022. In the medium and long term, we must also continue to work on ensuring that vaccines are not only produced in industrialized countries but also, for example, in African states.

Undoubtedly, we will continue to face new health challenges in the future, which is why a modern health system like that in Germany must always be further developed. For example, during the pandemic, we quickly realized how important it is to improve our reporting system in the health sector—from medical practices to laboratories and health authorities to the Robert Koch Institute, our central institution for disease monitoring and prevention.

Undoubtedly, digitalization plays an important role in gaining a comprehensive picture of the infection situation. The linking of information and a precise overview are of fundamental importance for optimizing methods of treatment and prevention, but also for political decisions. It has always been very important to me to seek expertise and advice from professionals in infectious diseases, immunology, health care in general, and also ethics. After all, successful pandemic control, which is a societal task, also requires an appropriate political framework.

To shed more light on current and future infection developments and to find the right answers, suitable platforms for exchange between science and politics, and of course also within the scientific community, are needed—not only at the national level but also at the international level. Especially when it comes to investigating the origins of new epidemics, I believe it is right for us to better position ourselves. Therefore, I welcome the establishment of the SAGO, the WHO Scientific Advisory Group for the Origins of Novel Pathogens, a new unit of researchers who will work together over a longer period. Their task will be to advise the WHO on the emergence of new or novel pathogens. This will help policymakers receive information about potentially concerning pathogens earlier and thus respond more quickly.

The basis for information and advice is data from the environment, wildlife, geography, sociology, and, not least, of course, from the health sector. The interdisciplinary and international collection, tracking, and analysis of this data is no easy task. All the more, I am pleased that we are creating a new space with the WHO Hub for Pandemic and Epidemic Intelligence in Berlin, where data for the prevention of further pandemics and epidemics can be analyzed and where the necessary tools can also be developed and tested. With the help of artificial intelligence, new connections in datasets can be discovered, which can then be further researched. The WHO Hub in Berlin will utilize these technical possibilities and share the findings with all states. This will allow health threats to be recognized more quickly and better, and to provide important decision-making bases for politics.

Let me conclude by summarizing, in three points, what I believe is fundamentally important.

First, we should ensure more collaboration and networking—in science, in politics, and between science and politics.

Second, we need efficient and functional structures. For this, the financing of the World Health Organization must be placed on a reliable foundation. After all, the WHO plays a central role as the coordinating body in the global health architecture. In addition, the mandates of all organizations and actors in global health should be clearly aligned with one another.

Third, we must continue to strengthen the trust that is essential for successful collaboration.

Pandemics know no national borders. Common challenges like this can only be overcome despite all national efforts when we act together. Instead of acting alone, we have a much better chance of successfully confronting the horrors of pandemics together. The current pandemic, with its catastrophic health and economic consequences, should be a lesson for us. We should build networks, structures, and trust, thus creating the prerequisites for ourselves and future generations to respond more quickly and effectively to health threats. We would do well to specifically enshrine measures for better prevention, early detection, and response in a pandemic treaty or another legal instrument.

There is certainly no shortage of discussion needs. Therefore, I wish you a fruitful exchange of ideas at this summit. And last but not least, I thank you all from the bottom of my heart for your commitment.